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Dear Editor,
We read the article titled ‘‘High levels of B-type
natriuretic peptide (BNP) predict weaning failure from
mechanical ventilation in adult patients after cardiac
surgery’’ by Thiago Martins Lara et al. with interest (1).
The authors aimed to evaluate whether serum levels of B-
type natriuretic peptide are a predictor of weaning failure
from mechanical ventilation after cardiac surgery. They
concluded that high BNP levels are predictive of failure to
wean from mechanical ventilation after cardiac surgery.
Plasma levels of BNP are increased in disorders asso-
ciated with intravascular volume overload, increased
central venous pressure and left ventricular dysfunction.
BNP secretion is directly proportional to left ventricular
wall stress and blood volume. Because of these associations,
there has been much interest in using BNP as a biomarker
for heart failure (2). However, high levels of BNP are
present in many cases for reasons unrelated to cardiac
diseases.
In several studies, BNP levels were higher in women than
in men, independent of age. Although the reason for this
difference is unknown, it is believed that estrogen may play
a role. Furthermore, levels of BNP increase with age, and
this difference is not associated with ‘‘age-related’’ diastolic
dysfunction in either sex (3). Obese individuals have low
circulating natriuretic peptide levels, and diabetes mellitus
is also associated with low plasma levels of natriuretic
peptide (4).
In addition, elevated BNP levels may be observed in
many diseases associated with hypervolemia, such as
chronic renal failure, chronic liver disease and hyperaldos-
teronism (5). Furthermore, respiratory conditions, such as
pulmonary embolism and chronic obstructive pulmonary
disease, are associated with high levels of BNP in the
absence of left heart failure.
One of the most important conditions associated with
elevated BNP levels is sepsis. Many studies have shown
significantly higher BNP levels in patients with sepsis, and
this effect was not related to myocardial dysfunction (6).
In conclusion, high levels of BNP are presented as a
predictive factor for failure to wean from mechanical
ventilation after cardiac surgery in the study by Thiago
Martins Lara et al. However, because BNP levels may be
affected by many factors, the significance of those risk
factors in weaning from mechanical ventilation after cardiac
surgery should be considered in future large-scale prospec-
tive randomized clinical trials.
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